Learn how breast cancer begins at the cell level, how tumors grow, what biomarkers like ER, PR, HER2, and Ki-67 mean, and why breast cancer can behave differently from one person to another.
Breast cancer biology is the study of how breast cells become abnormal, multiply, form tumors, interact with nearby tissue, and sometimes spread. Important biology markers include estrogen receptor, progesterone receptor, HER2, and Ki-67.
Breast cancer starts when normal breast cells acquire biological changes that allow them to grow and divide in an uncontrolled way. These abnormal cells may form a tumor, avoid normal cell death, and interact with the surrounding tissue.
Many breast cancers begin in the ducts or lobules. Ductal carcinoma starts in cells lining the milk ducts, while lobular carcinoma begins in the milk-producing lobules.
Many breast cancers begin in the milk ducts. These tumors may be in situ or invasive depending on whether cells remain inside the duct or grow into nearby tissue.
Some breast cancers begin in the lobules, the glands that produce milk. Lobular cancers can grow in patterns that may be harder to detect as a lump.
Invasive cancer means abnormal cells have moved beyond their original duct or lobule into surrounding breast tissue.
Breast cancers are commonly studied and classified using biomarkers. ER and PR show whether tumor cells may use hormone signals. HER2 shows whether cancer cells overexpress a growth-related receptor. Ki-67 is commonly used as a marker of cell proliferation.
Estrogen receptor. Helps identify hormone receptor-positive tumors.
Progesterone receptor. Often evaluated together with ER status.
A growth receptor that may be overexpressed or amplified in some tumors.
A proliferation marker that helps describe how actively cells are dividing.
Breast cancer is not one disease. Researchers often classify breast cancers into broad clinical groups using ER, PR, and HER2, and into intrinsic molecular subtypes such as Luminal A, Luminal B, HER2-enriched, basal-like, and normal-like.
| Subtype | Common biology pattern | Research focus |
|---|---|---|
| Luminal A | Often ER-positive, lower proliferation | Hormone signaling, endocrine response |
| Luminal B | Often ER-positive, higher proliferation | Ki-67, growth signaling, resistance biology |
| HER2-enriched | HER2 pathway activation | HER2 signaling, targeted therapy research |
| Basal-like / TNBC | Often ER-negative, PR-negative, HER2-negative | Immune biology, DNA repair, aggressive behavior |
A breast tumor is not only cancer cells. It can include immune cells, fibroblasts, blood vessels, extracellular matrix, adipocytes, and signaling molecules. This surrounding ecosystem is called the tumor microenvironment.
As tumors grow, they may stimulate new blood vessel formation, a process called angiogenesis. Some cancer cells can invade nearby tissue and may enter lymph vessels or blood vessels. When cancer spreads to distant organs, it is called metastasis.
Use these sources as reference links or image inspiration. Upload images to your own website only when the license allows reuse and attribution is included.
Breast cancer biology explains how breast cells become abnormal, multiply, form tumors, interact with surrounding tissue, and sometimes spread.
ER and PR are hormone receptors. HER2 is a growth-related receptor. These biomarkers help classify breast cancer biology and guide research and clinical understanding.
Triple-negative breast cancer lacks ER, PR, and HER2 expression. It is often studied for immune activity, DNA repair pathways, tumor heterogeneity, and aggressive growth behavior.
The tumor microenvironment is the surrounding ecosystem of cancer cells, immune cells, fibroblasts, blood vessels, matrix, fat cells, and signaling molecules that influence tumor behavior.